Health-Related Quality of Life Among Arrow Patients with Advanced or Metastatic RET-Altered Thyroid Cancers Treated with Pralsetinib (ATA 2026) - Sep 19, 2026 - Pres time: Nov 6, 2026; 05:30 PM - 06:30 PM; No abstract available
Clinical • HEOR • Metastases • Oncology • Solid Tumor • Thyroid Gland Carcinoma
|
|
Mimi Hu; Lori Wirth; Douglas Adkins; Myung-Ju Ahn; Guzmán Alonso; Christina S. Baik; Daniel W. Bowles; Marcia S. Brose; Giuseppe Curigliano; Julien Hadoux; Chia-Chi Lin; Gilberto de Lima Lopes; Aaron S. Mansfield; Martin Schuler; Matthew H. Taylor; Nathan Riley; Amber Thomassen; Justin F. Gainor; Vivek Subbiah
|